Recent quotes:

NIH’s funding cut plan poses challenges for researchers despite court halt

“If the on­ly way to get re­im­bursed for this mul­ti-mil­lion dol­lar equip­ment is to on­ly let one grant use it at a time, so that they can charge it as di­rect, that may be some­thing that we start to see,” he said. Re­gard­less of the out­come in court, Pe­tel said “peo­ple are go­ing to be more hes­i­tant to spend the time and ef­fort in putting to­geth­er grant ap­pli­ca­tions.” “It’s a lot of work, a lot of time, a lot of mon­ey to even ap­ply for these grants, and they go through months and months of scruti­ny and back and forth,” he said.

FDA and NIH let clinical trial sponsors keep results secret and break the law | Science | AAAS

The University of Texas MD Anderson Cancer Center and the Mayo Clinic both failed to report results on time, or at all, in about two-thirds of their trials. Yale University failed to do so in 84% of its trials. NIH’s own institutes also had a bad record. They are directly responsible for reporting results when they sponsor studies done by agency staff or some grantees, and the top four NIH institute sponsors, taken together, reported results late or not at all in more than six of every 10 trials Science looked at. Contacted for comment, none of the institutions disputed the findings of this investigation. In all 4768 trials Science checked, sponsors violated the reporting law more than 55% of the time. And in hundreds of cases where the sponsors got credit for reporting trial results, they have yet to be publicly posted because of quality lapses flagged by ClinicalTrials.gov staff (see sidebar).